KaloBios Pharmaceuticals said on Friday that it has emerged from bankruptcy, USA Today reported on Saturday. The former Martin Shkreli-led company also said that it had acquired the rights to develop benznidazole from Savant Neglected Diseases for $3 million. Benznidazole is a drug that helps treat Chagas disease, an infectious disease that affects 6 million to 7 million people worldwide. It is mainly found in Latin America. KaloBios filed for bankruptcy last December shortly after Shkreli was fired as its CEO after being arrested for alleged fraud charges that were unrelated to his brief time at KaloBios. He has denied the allegations.
